AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glycigon M OD 30mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Aristo Pharmaceuticals Pvt Ltd

Salt Composition

Gliclazide (30mg) + Metformin (500mg)

Overview Glycigon M OD 30mg/500mg Tablet

Diabex Duo 30mg/500mg tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This medication assists in regulating blood glucose levels. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation can lead to elevated glucose, risking kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications significantly influence diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Prompt glucose intake (sugary foods or juice) is essential for hypoglycemia management. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects are altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended.

Primary Ingredients of Glycigon M OD 30mg/500mg Tablet

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Glycigon M OD 30mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Glycigon M OD 30mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; do not chew, crush, or fracture it. The Glycigon M OD 30mg/500mg tablet should be administered with a meal.

Common Side effects of Glycigon M OD 30mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glycigon M OD 30mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glycigon M OD 30mg/500mg tablet whole; do not alter its form by chewing, crushing, or breaking. Administer this medication with a meal.

How Glycigon M OD 30mg/500mg Tablet works:

Each Glycigon M OD 30mg/500mg tablet combines gliclazide and metformin, two medications used to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glycigon M OD 30mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Glycigon M OD 30mg/500mg tablets is contraindicated during pregnancy due to documented harm to the fetus. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the risks. Physician consultation is mandatory.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glycigon M OD 30mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use the 30mg/500mg Glycigon M OD tablet cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Regular kidney function monitoring is recommended during treatment; consult your physician for guidance.

LiverLiverCAUTION

Patients with liver disease should use Glycigon M OD 30mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. For those with mild to moderate liver impairment, initiation at a lower dose is typical; however, the medication is unsuitable for patients exhibiting severe hepatic dysfunction.

What if you forget to take Glycigon M OD 30mg/500mg Tablet :

Should you forget to take your Glycigon M OD 30mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glycigon M OD 30mg/500mg Tablet

LabelValue
Potential for Dependence None.
Treatment Category Medication for diabetes

FAQs on Glycigon M OD 30mg/500mg Tablet

Glycigon M OD 30mg/500mg tablets contain gliclazide and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual-action therapy enhances blood sugar control when coupled with a healthy diet and regular physical activity. Gliclazide stimulates insulin secretion from the pancreas, while metformin reduces hepatic glucose production and increases insulin sensitivity. This formulation is unsuitable for type 1 diabetes.
Glycigon M OD 30mg/500mg tablets may cause common adverse reactions such as low blood glucose, taste disturbances, nausea, abdominal discomfort, loose stools, headache, and upper respiratory infections. Rare but potentially severe side effects, including lactic acidosis, are also possible. Prolonged administration may result in vitamin B12 deficiency.
Glycigon M OD 30mg/500mg Tablets can induce hypoglycemia. Low blood sugar symptoms may include nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and anxiety or tremors. Hypoglycemia risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carry glucose tablets, honey, or fruit juice for immediate treatment.
Glycigon M OD 30mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. This is also termed Metformin-associated lactic acidosis (MALA). While uncommon, this side effect necessitates caution, particularly in individuals with kidney impairment, the elderly, or those who consume significant alcohol. Symptoms such as muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, vomiting, abdominal pain, and bradycardia warrant immediate discontinuation of Glycigon M OD 30mg/500mg Tablets and prompt medical attention.
Glycigon M OD 30mg/500mg tablets may induce vitamin B12 deficiency with prolonged administration. This deficiency arises from the medication's interference with gastric vitamin B12 absorption. Untreated, this can lead to anemia, neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and ataxia. To mitigate these risks, supplemental vitamin B12 intake, at minimum annually, has been proposed by some investigators.
Patients exhibiting hypersensitivity to any Glycigon M OD 30mg/500mg Tablet ingredient or inactive component should not use this medication. Its use is also contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol concurrently with Glycigon M OD 30mg/500mg tablets is unsafe. This combination risks exacerbating hypoglycemia and elevating the probability of lactic acidosis.
Glycigon M 30mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This dual-action medication enhances blood sugar control when coupled with a healthy diet and physical activity. Gliclazide stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and boosts insulin effectiveness. This formulation is unsuitable for type 1 diabetes.
Glycigon M OD 30mg/500mg tablets may cause frequent adverse reactions such as low blood glucose, taste disturbances, queasiness, abdominal discomfort, loose stools, cephalalgia, and upper respiratory illnesses. Rare but potentially severe reactions, including lactic acidosis, are also possible. Prolonged treatment may result in vitamin B12 insufficiency.
Indeed, Glycigon M OD 30mg/500mg tablets can induce hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar may encompass nausea, headache, irritability, increased appetite, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The likelihood of hypoglycemia increases with skipped or delayed meals, alcohol consumption, strenuous physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is recommended.
Glycigon M OD 30mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon side effect of metformin. Its occurrence is reduced by avoiding use in individuals with kidney impairment, the elderly, or those consuming substantial alcohol. Symptoms potentially indicating lactic acidosis include muscular discomfort or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal pain, and bradycardia. Should these symptoms develop, discontinue Glycigon M OD 30mg/500mg Tablet use and seek immediate medical attention.
Indeed, prolonged administration of Glycigon M OD 30mg/500mg tablets can lead to vitamin B12 insufficiency. This deficiency arises from the medication's interference with the stomach's absorption of vitamin B12. Left unaddressed, this can result in anemia, neurological complications, including tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive impairment, and gait instability. To mitigate these risks, supplemental vitamin B12 intake, at least annually, has been proposed by some investigators.
Patients with hypersensitivity to Glycigon M OD 30mg/500mg Tablet constituents or inactive ingredients should not take this medication. Its use is also contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol while taking Glycigon M OD 30mg/500mg tablets is unsafe. This combination risks dangerously low blood sugar and heightened lactic acidosis probability.
Glycigon M OD 30mg/500mg ...
28
MRP 34
17% off